跳至主要内容
临床试验/CTRI/2023/10/059111
CTRI/2023/10/059111尚未招募Phase 3 4

A Comparative study to evaluate the efficacy of 0.75% Ropivacaine alone or combined with dexmedetomidine in supraclavicular brachial plexus block in upper limb surgeries.

Department of Anesthesia1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年12月9日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
入组人数
120
试验地点
1
主要终点
To determine whether the efficacy of 0.75% Ropivacaine with

研究概览

简要总结

it is a study to compare analgesic efficacy and motor blockade of 0.75% ropivacaine used alone or in combination with dexmedetomidine in upper limb surgeries.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Double Blind Double Dummy

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 120 patients of either sex, aged 18—60 years, belonging to American Society of Anesthesiologists (ASA) physical status class I and Il presenting for upper limb elective surgery under supraclavicular block.

排除标准

  • Who refuse to give consent.
  • With severe cardiac, renal, endocrine, pulmonary disease.
  • In physical status ASA grade Ill or higher.
  • Who are allergic to trial drugs.
  • Who are having local site infection.
  • With hemi-diaphragmatic paralysis on opposite side of surgery With any psychological disorder who would interfere with assessment of pain.
  • With history of brachial plexus injury.
  • With bilateral upper limb surgery and fracture.
  • With heart rate already on the lower side i.e 55 or less than 55b/m.

结局指标

主要结局

To determine whether the efficacy of 0.75% Ropivacaine with

时间窗: Onset & duration of Sensory block. Onset and duration of motor block. Duration of analgesia.

dexmedetomidine is greater than 0.75% Ropivacaine used alone in supraclavicular brachial plexus block for upper limb surgeries.

时间窗: Onset & duration of Sensory block. Onset and duration of motor block. Duration of analgesia.

次要结局

  • To compare the Hemodynamic parameters Complications.

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验